Back
Cara Therapeutics Stock Predictions
Sponsored
CARA
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
39
CARA
Cara Therapeutics
Last Price:
0.29
Seasonality Move:
5.28%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeCara Therapeutics Stock Forecast
-
Is Cara Therapeutics Stock Undervalued?
The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 39, which is 22% below its historic median score of 50, and infers higher risk than normal. - CARA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Cara Therapeutics Stock Go Up Next Year?
Data Unavailable
Cara Therapeutics Stock Rating
Data Unavailable
Cara Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
caratherapeutics.com
52-Week Data
52-Week High:
1.40
52-Week Low:
0.24
Prediction Charts
Market Cap:
15.93M
Price in USD:
0.29
Volume:
285.73K
Beta:
1.19
Technical Analysis
SMA50:
0.29
SMA100:
0.31
SMA200:
0.53
52-Wk Change:
-78.48%
Stock Predictions
-
Is Cara Therapeutics stock public?
Yes, Cara Therapeutics is a publicly traded company. -
What is the Cara Therapeutics stock quote today?
The Cara Therapeutics stock price is 0.29 USD today. -
How to buy Cara Therapeutics stock online?
You can buy Cara Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-15 | 0.25 | 0.26 | 0.26 | 0.25 |
Oct-16 | 0.26 | 0.27 | 0.27 | 0.25 |
Oct-18 | 0.26 | 0.27 | 0.27 | 0.26 |
Oct-21 | 0.27 | 0.27 | 0.27 | 0.26 |
Oct-22 | 0.27 | 0.27 | 0.27 | 0.26 |
Oct-23 | 0.27 | 0.27 | 0.28 | 0.26 |
Oct-24 | 0.27 | 0.25 | 0.27 | 0.25 |
Oct-25 | 0.25 | 0.27 | 0.27 | 0.25 |
Oct-28 | 0.27 | 0.27 | 0.28 | 0.27 |
Oct-29 | 0.27 | 0.27 | 0.29 | 0.26 |
Oct-30 | 0.26 | 0.29 | 0.31 | 0.26 |
Oct-31 | 0.29 | 0.31 | 0.32 | 0.28 |
Nov-1 | 0.31 | 0.30 | 0.31 | 0.29 |
Nov-4 | 0.29 | 0.29 | 0.30 | 0.28 |
Cara Therapeutics Earnings
Data Unavailable
Cara Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.50 per share.
* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.